Precious Bodily Fluids: David Spiegel on the treatment of dialysis patients

Friday, May 21, 2010

David Spiegel on the treatment of dialysis patients

There are only two outcomes that are important: quantity of life and quality of life. We don't know how to measure quality of life and haven't shown an ability to change the former.

- Posted using BlogPress from my iPad

Joel Topf, MD FACP

I am a board certified clinical nephrologist in Detroit. I am a partner at St Clair Nephrology. I am an Assistant Clinical Professor at Oakland University William Beaumont School of Medicine and part of the faculty for The St John Hospital and Medical Center Nephrology Fellowship. I have an offices at St Johns Moross, Roseville and Farmington Hills. I am the medical director of St Clair Nephrology Research.

The best way to contact me is by twitter @Kidney_boy, (check out my best tweets at Favstar) or Facebook.

COI: I am on the speakers bureau for Astute Medical. I have an ownership stake in four Davita run dialysis clinics and one vascular access center. Astellas paid for my trip to Australia (Feb '15) for me to speak at one meeting and three hospitals. Takeda Oncology made a donation to MM4MM the program that is taking me to Mount Everest in 2018.

Pages

Friday, May 21, 2010

David Spiegel on the treatment of dialysis patients